CompletedNCT05089565

Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

Studying Sarcoidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Northwestern University
Principal Investigator
Peter Sporn, MD
Northwestern University Feinberg School of Medicine
Intervention
Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation(diagnostic_test)
Enrollment
101 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2022

Study locations (1)

Collaborators

Foundation for Sarcoidosis Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05089565 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

See all trials for Sarcoidosis →

← Back to all trials